Infinity Announces the Date of Its Full-Year 2012 Financial Results
Conference Call and Webcast
CAMBRIDGE, Mass. -- February 19, 2013
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on
Tuesday, March 5, 2013, at 4:30 p.m. ET. During the call, management will
provide an update on Infinity's business and discuss the company's full-year
2012 financial results.
A live webcast of the conference call can be accessed in the Investors/Media
section of Infinity's website at www.infi.com. To participate in the
conference call, please dial 1-877-316-5293 (domestic) and 1-631-291-4526
(international) five minutes prior to start time. The conference ID number is
99040593. An archived version of the webcast will be available on Infinity's
website for 30 days.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative drug discovery and development company seeking to
discover, develop and deliver to patients best-in-class medicines for diseases
with significant unmet need. Infinity combines proven scientific expertise
with a passion for developing novel small molecule drugs that target emerging
disease pathways. Infinity’s programs focused on the inhibition of
phosphoinositide-3-kinase and heat shock protein 90 are evidence of its
innovative approach to drug discovery and development. For more information on
Infinity, please refer to the company’s website at www.infi.com.
Infinity Pharmaceuticals, Inc.
Kate Murray, 617-453-1179
Press spacebar to pause and continue. Press esc to stop.